Quantum International Income Corp. Announces Addition of Surgeons and Broadening of Surgical Practice Areas at Centers for Special Surgery ("CSS")

/THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./

TORONTO, Aug. 21, 2015 /CNW/ - Quantum International Income Corp. ("QIIC" or the "Company") (TSXV: QIC / QIC.U), a Healthcare company focused on providing superior patient care through the delivery of integrated health solutions, is pleased to announce, QIIC's partner in CSS, New York City Surgical Associates ("NYCSA") has added three new highly regarded surgeons to their physician practice that will be performing surgeries at CSS Essex.

The additional of these high profile surgeons is expected to result in increased facility profitability in addition to added anesthesia revenues.

Dr. Arien Smith is a board certified and fellowship trained spine surgeon, and Director of the Neurosurgery and Spine Division at NYC Surgical Associates. His practice includes both adult and pediatric spinal disorders. Dr Smith has the rare combination of subspecialty training in both orthopedic and neurosurgical spine surgery for chronic, acute, and traumatic issues. He also brings to NYC Surgical Associates his experience in pediatric deformity and scoliosis surgery.

Dr. Victor I. Rosenberg, M.D., F.A.C.S., has been a Diplomat of the American Board of Plastic Surgery since 1969, after having completed four years of training in General Surgery followed by three more years of training in Plastic Surgery. For twenty years he was the director of Plastic Surgery at NYU Downtown Hospital. In addition, he has enjoyed a long time affiliation with Beth Israel Medical Center and The Mount Sinai Medical Center and for many years has been on the staff of Mount Sinai School of Medicine. 

Dr. Rosenberg has been featured on many TV shows. Amongst them are 'Oprah Winfrey,' 'Donahue,' 'Maury Povich,' 'Joan Rivers,' 'Live with Regis and Kathy Lee,' 'Mike Douglas' and on many national and local news shows. His numerous radio appearances include 'Sally Jessy Raphael.' He has been interviewed in numerous newspapers and magazines, including The New York Times, New York Post, Daily News, The New York Times Magazine, Harper's Bazaar, Vogue, Allure, Cosmopolitan, US, Self and Ladies Home Journal.

Dr. Elie S. Semaan is a double board certified Vascular and Endovascular Surgeon, and the Director of the Division of Vascular Surgery at NYC Surgical Associates. His undergraduate training was performed at University of California Los Angeles, and residency training at Maimonides Medical Center in Brooklyn, NY, where his surgical experience spanned from general and minimally invasive surgery to critical care, vascular surgery, and cardiothoracic surgery. Prior to joining the staff at NYC Surgical he was a Clinical Professor of Surgery at the University of Arizona, and one of the founding members of Banner Heart Hospital in Mesa, AZ, as well as Assistant Clinical Professor at Weill Cornell Medical Center in New York, NY.

Grant White, Chief Executive Officer of Quantum commented "We are delighted with the addition of these surgeons to the NYCS team.  In our last quarter we turned a profit at CSS. The operating costs are relatively stable and fixed at CSS, as such a sizable portion of the revenue from each of these surgeons performed in our centers will drop to the bottom line.  In addition, Quantum Anesthesia will also profit from the increase in surgical volumes."

Stock Options Grant

Also, the Company announces the granting of stock options to its directors, officers and other plan participants to purchase up to 7,525,000 common shares of the Corporation, 7,325,000 of which have an exercise price of CDN $0.42 for a period of five years and 200,000 of which have an exercise price of CDN $0.35 for period of five years. The 200,000 above mentioned options were previously approved by the board in December 2014 however were not issued due to Company blackout policy.

All of the stock options to purchase common shares of the Corporation are subject to vesting as to one third on the date of the grant, one third a year from the date of grant and the remaining one third vesting two years from the date of grant. The stock options were granted pursuant to the Stock Option Plan of the Corporation, which received shareholder approval at the annual and special meeting of shareholders of the Corporation on November 21, 2013. The granting of the stock options to purchase common shares of the Corporation is subject to applicable stock exchange and regulatory approvals.

The options were granted according to the table below:

Name	Position	Options Granted
Grant White	Director, Chief Executive Officer	3,400,000
Manu K. Sekhri	Director, President	3,400,000
Roy L. Booth	Chief Financial Officer	250,000
Douglas Stuve	Director	125,000
Sheila Ogilvie-Harris	Director	125,000
Geoffrey Boothe	Director	125,000
Anton Scheglov	Controller	100,000

 About Quantum International Income Corp.

Quantum is a healthcare company focused on delivering national integrated health solutions in the United States. The Corporation seeks to back management teams with strong operational track records and deep healthcare experience. The Corporation intends for acquired businesses or assets to fit synergistically within a strategic framework, have a proven operating history, opportunities for standalone growth and, potentially in some cases, national expansion. Potential acquisition targets will be in various related areas of the United States healthcare industry in different geographic regions to allow for diversification.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE Quantum International Income Corp

please contact Quantum International Income Corp.: Grant White, Chief Executive Officer, Tel. [phone], [email protected]; Manu K. Sekhri, President, Tel. [phone], [email protected]; Investor Relations: Kin Communications, Joel Kitsul - Sr. VP Investor Relations, 1-866-684-6730, [email protected]